8.20 USD
▼-0.27-3.19%
盘后 8.83 0.00%
2026-11-19
市值
$7.24B
市盈率
10.34
EPS
0.79
股息率
3.35%
52 周区间
6.96 – 9.77
成交量
436.51K
Beta
1.13
目标价
10.37
52W 低 6.9652W 高 9.77
价格走势

公司简介

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as wel...